These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16905325)

  • 1. No evidence of association between BDNF gene variants and age-at-onset of Huntington's disease.
    Di Maria E; Marasco A; Tartari M; Ciotti P; Abbruzzese G; Novelli G; Bellone E; Cattaneo E; Mandich P
    Neurobiol Dis; 2006 Nov; 24(2):274-9. PubMed ID: 16905325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington's disease.
    Kishikawa S; Li JL; Gillis T; Hakky MM; Warby S; Hayden M; MacDonald ME; Myers RH; Gusella JF
    Neurobiol Dis; 2006 Nov; 24(2):280-5. PubMed ID: 16962786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between BDNF Val66Met polymorphism and age at onset in Huntington disease.
    Alberch J; López M; Badenas C; Carrasco JL; Milà M; Muñoz E; Canals JM
    Neurology; 2005 Sep; 65(6):964-5. PubMed ID: 16186551
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease.
    Nazé P; Vuillaume I; Destée A; Pasquier F; Sablonnière B
    Neurosci Lett; 2002 Aug; 328(1):1-4. PubMed ID: 12123845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association between polymorphisms in the BDNF gene and age at onset in Huntington disease.
    Mai M; Akkad AD; Wieczorek S; Saft C; Andrich J; Kraus PH; Epplen JT; Arning L
    BMC Med Genet; 2006 Nov; 7():79. PubMed ID: 17096834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age at onset in Huntington's disease: replication study on the association of HAP1.
    Karadima G; Dimovasili C; Koutsis G; Vassilopoulos D; Panas M
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1027-8. PubMed ID: 22698993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the functional brain-derived neurotrophic factor gene variant Val66MET in migraine.
    Marziniak M; Herzog AL; Mössner R; Sommer C
    J Neural Transm (Vienna); 2008 Sep; 115(9):1321-5. PubMed ID: 18478177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.
    Henley SM; Wild EJ; Hobbs NZ; Scahill RI; Ridgway GR; Macmanus DG; Barker RA; Fox NC; Tabrizi SJ
    J Neurol; 2009 Feb; 256(2):203-12. PubMed ID: 19266143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons.
    Takahashi T; Suzuki M; Tsunoda M; Kawamura Y; Takahashi N; Tsuneki H; Kawasaki Y; Zhou SY; Kobayashi S; Sasaoka T; Seto H; Kurachi M; Ozaki N
    Neurosci Lett; 2008 Apr; 435(1):34-9. PubMed ID: 18325670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of HD and UCHL-1 genes in Huntington's disease.
    Xu EH; Tang Y; Li D; Jia JP
    J Clin Neurosci; 2009 Nov; 16(11):1473-7. PubMed ID: 19683447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans.
    Ribeiro L; Busnello JV; Cantor RM; Whelan F; Whittaker P; Deloukas P; Wong ML; Licinio J
    Neuroreport; 2007 Aug; 18(12):1291-3. PubMed ID: 17632285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease.
    Metzger S; Bauer P; Tomiuk J; Laccone F; Didonato S; Gellera C; Mariotti C; Lange HW; Weirich-Schwaiger H; Wenning GK; Seppi K; Melegh B; Havasi V; Balikó L; Wieczorek S; Zaremba J; Hoffman-Zacharska D; Sulek A; Basak AN; Soydan E; Zidovska J; Kebrdlova V; Pandolfo M; Ribaï P; Kadasi L; Kvasnicova M; Weber BH; Kreuz F; Dose M; Stuhrmann M; Riess O
    Hum Genet; 2006 Sep; 120(2):285-92. PubMed ID: 16847693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical association of the brain-derived-neurotrophic-factor val66met genotype with response inhibition.
    Beste C; Baune BT; Domschke K; Falkenstein M; Konrad C
    Neuroscience; 2010 Mar; 166(1):178-84. PubMed ID: 20034542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.
    Andresen JM; Gayán J; Cherny SS; Brocklebank D; Alkorta-Aranburu G; Addis EA; ; Cardon LR; Housman DE; Wexler NS
    J Med Genet; 2007 Jan; 44(1):44-50. PubMed ID: 17018562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.
    Petracca M; Di Tella S; Solito M; Zinzi P; Lo Monaco MR; Di Lazzaro G; Calabresi P; Silveri MC; Bentivoglio AR
    Eur J Neurol; 2022 Jul; 29(7):1940-1951. PubMed ID: 35357736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset Huntington's disease with 40-42 CAG expansion.
    Capiluppi E; Romano L; Rebora P; Nanetti L; Castaldo A; Gellera C; Mariotti C; Macerollo A; Cislaghi MG
    Neurol Sci; 2020 Apr; 41(4):869-876. PubMed ID: 31820322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
    Miyajima F; Ollier W; Mayes A; Jackson A; Thacker N; Rabbitt P; Pendleton N; Horan M; Payton A
    Genes Brain Behav; 2008 Jun; 7(4):411-7. PubMed ID: 17973920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset Huntington disease with intermediate CAG repeats: true or false?
    Groen JL; de Bie RM; Foncke EM; Roos RA; Leenders KL; Tijssen MA
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):228-30. PubMed ID: 20145031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.